BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 560 filers reported holding BIO-TECHNE CORP in Q2 2024. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $74,229 | +1.8% | 1,036 | 0.0% | 0.06% | 0.0% |
Q1 2024 | $72,924 | -8.8% | 1,036 | 0.0% | 0.06% | -11.0% |
Q4 2023 | $79,938 | +13.4% | 1,036 | 0.0% | 0.07% | -11.0% |
Q3 2023 | $70,521 | -16.6% | 1,036 | 0.0% | 0.08% | -29.3% |
Q2 2023 | $84,569 | +10.0% | 1,036 | 0.0% | 0.12% | 0.0% |
Q1 2023 | $76,861 | -10.5% | 1,036 | 0.0% | 0.12% | -17.7% |
Q4 2022 | $85,864 | +16.0% | 1,036 | +300.0% | 0.14% | -3.4% |
Q3 2022 | $74,000 | -17.8% | 259 | 0.0% | 0.15% | -13.1% |
Q2 2022 | $90,000 | -19.6% | 259 | 0.0% | 0.17% | -0.6% |
Q1 2022 | $112,000 | -16.4% | 259 | 0.0% | 0.17% | -9.6% |
Q4 2021 | $134,000 | +6.3% | 259 | 0.0% | 0.19% | 0.0% |
Q3 2021 | $126,000 | +7.7% | 259 | 0.0% | 0.19% | +8.1% |
Q2 2021 | $117,000 | +18.2% | 259 | 0.0% | 0.17% | +16.1% |
Q1 2021 | $99,000 | +20.7% | 259 | 0.0% | 0.15% | +15.5% |
Q4 2020 | $82,000 | +28.1% | 259 | 0.0% | 0.13% | -41.6% |
Q3 2020 | $64,000 | -5.9% | 259 | 0.0% | 0.22% | -11.2% |
Q2 2020 | $68,000 | +38.8% | 259 | 0.0% | 0.25% | +27.7% |
Q1 2020 | $49,000 | -14.0% | 259 | 0.0% | 0.20% | +12.1% |
Q4 2019 | $57,000 | +11.8% | 259 | 0.0% | 0.17% | +3.6% |
Q3 2019 | $51,000 | -66.7% | 259 | -64.7% | 0.17% | -61.1% |
Q2 2019 | $153,000 | +200.0% | 734 | +183.4% | 0.43% | +149.7% |
Q1 2019 | $51,000 | +6.2% | 259 | 0.0% | 0.17% | +9.5% |
Q4 2018 | $48,000 | – | 259 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Summit Creek Advisors LLC | 143,734 | $14,611,000 | 3.07% |
Brown Capital Management | 2,147,690 | $218,313,000 | 2.91% |
STONE RUN CAPITAL, LLC | 42,925 | $4,364,000 | 2.62% |
Select Equity Group, L.P. | 2,432,176 | $247,230,690,000 | 1.84% |
MAIRS & POWER INC | 1,389,850 | $141,278,000 | 1.73% |
Conestoga Capital Advisors, LLC | 256,213 | $26,044,000 | 1.57% |
QUANTUM CAPITAL MANAGEMENT | 59,798 | $6,078,000 | 1.51% |
First Light Asset Management, LLC | 38,202 | $3,883,000 | 1.48% |
SEGALL BRYANT & HAMILL, LLC | 570,853 | $58,027,000 | 1.40% |
RIVERBRIDGE PARTNERS LLC | 604,797 | $61,478,000 | 1.24% |